跳至主要内容
临床试验/NCT00636766
NCT00636766已完成不适用

Atherosclerotic Plaque Texture-Experimental and Clinical Study on the Diagnostic and Therapeutic Strategies of Atherosclerotic Plaque Vulnerability

Aristotle University Of Thessaloniki1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2005年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
Ultrasound and immunohistochemical parameters of plaque stability; novel cardiovascular risk factors

研究概览

简要总结

The aim of the present study is to examine the atherosclerotic plaque stability using in vivo and in vitro techniques and to investigate the influence of exercise, anti-diabetic, lipid-lowering and cannabinoids receptor antagonists on atherosclerotic plaque texture in patients with cardiovascular risk and animals prone to atherosclerosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Carotid atherosclerosis
  • Femoral atherosclerosis
  • Cardiovascular risk

排除标准

  • Heart failure
  • Renal disease
  • Liver disease
  • Life-threatening diseases

研究组 & 干预措施

1

Experimental

干预措施: atorvastatin (Drug)

1

Experimental

干预措施: rimonabant (Drug)

1

Experimental

干预措施: rosiglitazone (Drug)

1

Experimental

干预措施: metformin (Drug)

结局指标

主要结局

Ultrasound and immunohistochemical parameters of plaque stability; novel cardiovascular risk factors

时间窗: 3 years

次要结局

  • Long-term cardiovascular outcomes(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nikolaos Kadoglou

MD,PhD

Aristotle University Of Thessaloniki

研究点 (1)

Loading locations...

相似试验